pharmaphorum

SEPTEMBER 16, 2022

A notable issue with clinical trials is the homogeneity of the patient database. Dr. Charlie Kim earned his PhD from Microbiology and Immunology at Stanford University and pioneered the application of genomic and bioinformatic approaches to the study of infectious disease. About the interviewee.

Development 133

Development Research Drugs Clinical Trials 133

Drug Discovery World

APRIL 14, 2023

He is being recognised for illuminating research contributions to defining the links between chromosomal abnormalities and cancer, including his discovery of TMPRSS2-ETS gene fusions in prostate cancer, and for pioneering the use of pathological and bioinformatic methodologies to diagnose and track prostate cancer onset and progression.

Genetics 52

Genetics Research Medicine Clinical Research 52

STAT News

MARCH 6, 2023

“There isn’t a member of the board of JLF who wouldn’t rather be able to do this without charging people,” said Andrew Jacobs, who sits on the boards of the foundation and NorRD Bio, a small Cambridge bioinformatics firm that helps make the vaccines. “It really was a choice of this or nothing.”

Vaccination 98

Vaccination Vaccine Drugs Clinical Trials 98

Drug Discovery World

FEBRUARY 6, 2023

Johannes Goll, Global Head of Emmes’ Biomedical Data Science and Bioinformatics department, explains how big data analytics can deliver improved therapies and bring clinical research one step close to realising the potential of personalised care.

Big Data 52

Big Data RNA Bioinformatics Vaccination 52

Drug Discovery World

APRIL 29, 2024

Bill Dawson, Chair, Medicines Manufacturing Industry Partnership (MMIP): Dawson is Head of Biologics and Devices Manufacturing at GSK and has over 25 years’ experience in the vaccines, biopharma, pharmaceutical and clinical research (CRO) industries. He has a PhD in Bioinformatics from the University of Cambridge.

Drugs 52

Drugs Sales Gene Therapy Life Science 52

XTalks

NOVEMBER 7, 2022

“Liquid biopsies have demonstrated promising activity in multiple clinical settings, but the great enthusiasm and expectations around them can be harmful if not adequately managed,” said Dr. El Mustapha Bahassi, PhD, Director, Clinical Laboratory Sciences, at the global clinical research organization (CRO) Medpace.

Clinical Trials 98

Clinical Trials Clinical Trials Trials FDA Approval 98

The Pharma Data

SEPTEMBER 1, 2020

study investigator and Professor of Clinical Neurology, University of California San Francisco (UCSF) Weill Institute for Neurosciences and clinical research director, UCSF MS Center. Presentation Topic: Biomarkers and Bioinformatics. In the DAYBREAK trial, of 2,494 participants exposed to Zeposia for a total of 35.4

Trials 52

Trials Clinical Trials Clinical Trials Vaccination 52

Roots Analysis

AUGUST 28, 2022

Recent advances in multi-omics approaches, including genomics, transcriptomics, proteomics, metabolomics, cytometry and imaging, in combination with bioinformatics and biostatistics, have been translated into several popular bioanalytical platforms, such as next-generation sequencing (NGS), single-cell analysis, flow cytometry and mass spectrometry.

Genome 52

Genome Genomics RNA Genome Project 52

XTalks

SEPTEMBER 5, 2023

The clinical trial landscape overall has evolved significantly with key changes in the social, ethical and regulatory environment globally with the creation of guidance by regulators with new regulatory pathways for approval of products specifically developed for diseases in LMIC and public health emergencies.

Vaccination 96

Vaccination Vaccine Development Clinical Trials 96